• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病的开放式手术治疗。

Open Surgical Therapy for Peripheral Artery Disease.

机构信息

Department of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Department of Surgery, Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

出版信息

Curr Cardiol Rep. 2024 Apr;26(4):211-220. doi: 10.1007/s11886-024-02027-4. Epub 2024 Feb 12.

DOI:10.1007/s11886-024-02027-4
PMID:38342801
Abstract

PURPOSE OF REVIEW

The surgical management of symptomatic peripheral artery disease (PAD) has changed in the last few decades. Improvement in endovascular technology has resulted in more complex lesion once reserved for open surgery being addressed in an endovascular fashion. Even with these advances, there are lesions and patients that are better managed with an open surgical procedure. The aim of this review is to describe the most commonly performed open surgical procedures for PAD.

RECENT FINDINGS

The recently published Best Endovascular versus Best Surgical Therapy (BEST-CLI) trial was an international, prospective, randomized controlled trial that aimed to investigate which revascularization (endovascular vs. surgical bypass) approach was superior for limb salvage. The evidence supports an open surgical bypass as an initial approach. The advancements made in the surgical management of PAD have provided options for patients who were once deemed poor surgical candidates. The goal continues to be utilization of the best available tools to address patient disease. In this current era, it is important to be familiar with the open surgical therapies.

摘要

目的综述

过去几十年中,症状性外周动脉疾病(PAD)的外科治疗发生了变化。腔内技术的改进使曾经保留用于开放手术的更复杂病变得以通过腔内方式解决。即使有了这些进步,仍有一些病变和患者通过开放手术治疗效果更好。本文的目的是描述 PAD 最常进行的开放手术。

最新发现

最近发表的最佳腔内治疗与最佳手术治疗(BEST-CLI)试验是一项国际、前瞻性、随机对照试验,旨在探讨哪种血运重建(腔内治疗与旁路手术)方法对肢体挽救更有效。证据支持开放旁路手术作为初始治疗方法。PAD 的外科治疗进展为曾经被认为是手术禁忌的患者提供了选择。目标仍然是利用最好的可用工具来解决患者的疾病。在当前这个时代,熟悉开放手术治疗非常重要。

相似文献

1
Open Surgical Therapy for Peripheral Artery Disease.外周动脉疾病的开放式手术治疗。
Curr Cardiol Rep. 2024 Apr;26(4):211-220. doi: 10.1007/s11886-024-02027-4. Epub 2024 Feb 12.
2
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.在BEST-CLI试验中,女性患者的肢体截肢情况比男性患者少。
J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
3
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
4
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.BEST-CLI试验中慢性肾脏病患者慢性肢体威胁性缺血血运重建的结果
J Vasc Surg. 2025 Apr;81(4):945-956.e3. doi: 10.1016/j.jvs.2024.12.128. Epub 2025 Jan 23.
5
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.药物洗脱球囊血管成形术与未涂层球囊血管成形术治疗下肢外周动脉疾病的比较。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD011319. doi: 10.1002/14651858.CD011319.pub2.
6
Editor's Choice - Bypass After Failed Endovascular Intervention Is Associated with an Increased Risk of Above Ankle Amputation Among Patients with Chronic Limb Threatening Ischaemia in a Randomised Trial Population.编辑推荐——在一项随机试验人群中,对于患有慢性肢体威胁性缺血的患者,血管内介入治疗失败后进行旁路手术与踝关节以上截肢风险增加相关。
Eur J Vasc Endovasc Surg. 2025 Jul;70(1):107-113. doi: 10.1016/j.ejvs.2025.04.001. Epub 2025 Apr 4.
7
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.严重肢体缺血患者最佳血管内治疗与最佳手术治疗对比试验(BEST-CLI)的设计与原理
J Am Heart Assoc. 2016 Jul 8;5(7):e003219. doi: 10.1161/JAHA.116.003219.
8
Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease.针对因不可重建的外周动脉疾病导致的严重下肢缺血的腰交感神经切除术技术
Cochrane Database Syst Rev. 2016 Dec 13;12(12):CD011519. doi: 10.1002/14651858.CD011519.pub2.
9
Endovascular treatment for ruptured abdominal aortic aneurysm.破裂性腹主动脉瘤的血管内治疗
Cochrane Database Syst Rev. 2017 May 26;5(5):CD005261. doi: 10.1002/14651858.CD005261.pub4.
10
Factors associated with 90-day reintervention following lower extremity revascularization.与下肢血运重建后 90 天再干预相关的因素。
J Vasc Surg. 2024 Jul;80(1):213-222.e1. doi: 10.1016/j.jvs.2024.03.009. Epub 2024 Mar 8.

引用本文的文献

1
Computational modeling of drug-eluting balloons in peripheral artery disease: Mechanisms, optimization, and translational insights.外周动脉疾病中药物洗脱球囊的计算建模:机制、优化及转化见解。
Comput Struct Biotechnol J. 2025 Aug 7;27:3640-3653. doi: 10.1016/j.csbj.2025.08.005. eCollection 2025.

本文引用的文献

1
Outcomes of axillofemoral bypass for intermittent claudication.间歇性跛行患者腋股动脉旁路移植术的治疗结果。
J Vasc Surg. 2022 May;75(5):1687-1694.e4. doi: 10.1016/j.jvs.2021.12.048. Epub 2021 Dec 24.
2
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.下肢外周动脉疾病:当代流行病学、管理差距与未来方向:美国心脏协会科学声明。
Circulation. 2021 Aug 31;144(9):e171-e191. doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.
3
Interpretation of peripheral arterial and venous Doppler waveforms: A consensus statement from the Society for Vascular Medicine and Society for Vascular Ultrasound.
周围动脉和静脉多普勒波形的解读:血管医学学会和血管超声学会的共识声明。
Vasc Med. 2020 Oct;25(5):484-506. doi: 10.1177/1358863X20937665. Epub 2020 Jul 15.
4
Laparotomy- and groin-associated complications are common after aortofemoral bypass and contribute to reintervention.腹主动脉-股动脉旁路手术后常见的腹股沟相关并发症,并导致再次干预。
J Vasc Surg. 2020 Dec;72(6):1976-1986. doi: 10.1016/j.jvs.2019.09.067. Epub 2020 Apr 10.
5
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
6
Association between statin use and perioperative mortality after aortobifemoral bypass in patients with aortoiliac occlusive disease.他汀类药物使用与腹主动脉-股动脉旁路移植术后合并主髂动脉闭塞性疾病患者围手术期死亡率的关系。
J Vasc Surg. 2019 Aug;70(2):509-515. doi: 10.1016/j.jvs.2018.10.120. Epub 2019 Mar 2.
7
Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.关键肢体缺血管理的长期结局和成本的决定因素:一项基于人群的队列研究。
J Am Heart Assoc. 2018 Aug 21;7(16):e009724. doi: 10.1161/JAHA.118.009724.
8
Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease.主-股动脉旁路移植术治疗主-髂动脉闭塞性疾病的30年趋势
J Vasc Surg. 2018 Dec;68(6):1796-1804.e2. doi: 10.1016/j.jvs.2018.01.067. Epub 2018 Jul 9.
9
Improved patency after axillofemoral bypass for aortoiliac occlusive disease.主动脉髂动脉闭塞性疾病行腋股动脉搭桥术后通畅率提高。
J Vasc Surg. 2018 Nov;68(5):1430-1437. doi: 10.1016/j.jvs.2018.01.061. Epub 2018 Aug 9.
10
Estimated annual health care expenditures in individuals with peripheral arterial disease.外周动脉疾病患者的年估计医疗保健支出。
J Vasc Surg. 2018 Feb;67(2):558-567. doi: 10.1016/j.jvs.2017.06.102. Epub 2017 Aug 25.